FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2989402405> ?p ?o ?g. }

• W2989402405 endingPage "50" @default.
• W2989402405 startingPage "41" @default.
• W2989402405 abstract "Cholangiocarcinoma (CCA) is from cholangiocytes, and therefore bile is a potentially rich source of biomarkers for CCA. The aim of the study was to identify and validate microRNAs (miRNAs) in bile samples that are differentially expressed between benign biliary disease (BBD) and CCA. Bile samples from 106 patients with obstructive biliary disease were allocated consecutively to a discovery set (10 patients with BBD and 11 with CCA) and then a validation set (48 patients with BBD and 37 with CCA). An miRNA microarray platform was used to screen 1209 miRNAs in the discovery set. Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) was used to validate the profiling results in the discovery and validation sets. In addition, the levels of carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA) were determined from patient serum samples. Microarray profiling showed that miR-30d-5p and miR-92a-3p were significantly upregulated in bile from the CCA group compared with those from the BBD group. qRT-PCR results indicated that the expression levels of miR-30d-5p and of miR-92a-3p were significantly upregulated in the CCA group compared to the BBD group, validating the miRNA microarray results. Pathway analysis suggested that putative target genes of miR-30d-5p and of miR-92a-3p were involved in CCA-associated signalling pathways, such as Hippo, Wnt, p53, MAPK, and EGFR. Receiver operating curve analysis revealed that the areas under the curve for bile miR-30d-5p, miR-92a-3p, serum CA19-9, and CEA were 0.730, 0.652, 0.675, and 0.603, respectively, and bile miR-30d-5p showed the best diagnostic performance with a sensitivity of 81.1% and a specificity of 60.5%. The levels of extracellular miR-30d-5p and miR-92a-3p in bile were significantly higher in patients with CCA than those in patients with BBD. Bile-derived circulating extracellular miR-30d-5p and miR-92a-3p are potential biomarkers for discriminating CCA from BBD." @default.
• W2989402405 created "2019-11-22" @default.
• W2989402405 creator A5000021239 @default.
• W2989402405 creator A5009903231 @default.
• W2989402405 creator A5030819901 @default.
• W2989402405 creator A5069818368 @default.
• W2989402405 creator A5076196426 @default.
• W2989402405 creator A5079922221 @default.
• W2989402405 creator A5084687090 @default.
• W2989402405 creator A5089039848 @default.
• W2989402405 date "2020-02-01" @default.
• W2989402405 modified "2023-10-15" @default.
• W2989402405 title "Bile-derived circulating extracellular miR-30d-5p and miR-92a-3p as potential biomarkers for cholangiocarcinoma" @default.
• W2989402405 cites W154093113 @default.
• W2989402405 cites W1864931156 @default.
• W2989402405 cites W1967951903 @default.
• W2989402405 cites W2000465242 @default.
• W2989402405 cites W2002830509 @default.
• W2989402405 cites W2026703961 @default.
• W2989402405 cites W2028700227 @default.
• W2989402405 cites W2057062911 @default.
• W2989402405 cites W2064912712 @default.
• W2989402405 cites W2071941078 @default.
• W2989402405 cites W2092840595 @default.
• W2989402405 cites W2094077020 @default.
• W2989402405 cites W2105549148 @default.
• W2989402405 cites W2117651804 @default.
• W2989402405 cites W2128340149 @default.
• W2989402405 cites W2130538069 @default.
• W2989402405 cites W2147681868 @default.
• W2989402405 cites W2158667042 @default.
• W2989402405 cites W2162674813 @default.
• W2989402405 cites W2271920132 @default.
• W2989402405 cites W2405504226 @default.
• W2989402405 cites W2497076903 @default.
• W2989402405 cites W2550810304 @default.
• W2989402405 cites W2724399456 @default.
• W2989402405 cites W2752020642 @default.
• W2989402405 cites W2792724222 @default.
• W2989402405 cites W2799819709 @default.
• W2989402405 cites W2801120450 @default.
• W2989402405 cites W2801634881 @default.
• W2989402405 cites W2891205406 @default.
• W2989402405 cites W4211025847 @default.
• W2989402405 doi "https://doi.org/10.1016/j.hbpd.2019.10.009" @default.
• W2989402405 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31784323" @default.
• W2989402405 hasPublicationYear "2020" @default.
• W2989402405 type Work @default.
• W2989402405 sameAs 2989402405 @default.
• W2989402405 citedByCount "25" @default.
• W2989402405 countsByYear W29894024052020 @default.
• W2989402405 countsByYear W29894024052021 @default.
• W2989402405 countsByYear W29894024052022 @default.
• W2989402405 countsByYear W29894024052023 @default.
• W2989402405 crossrefType "journal-article" @default.
• W2989402405 hasAuthorship W2989402405A5000021239 @default.
• W2989402405 hasAuthorship W2989402405A5009903231 @default.
• W2989402405 hasAuthorship W2989402405A5030819901 @default.
• W2989402405 hasAuthorship W2989402405A5069818368 @default.
• W2989402405 hasAuthorship W2989402405A5076196426 @default.
• W2989402405 hasAuthorship W2989402405A5079922221 @default.
• W2989402405 hasAuthorship W2989402405A5084687090 @default.
• W2989402405 hasAuthorship W2989402405A5089039848 @default.
• W2989402405 hasConcept C104317684 @default.
• W2989402405 hasConcept C121608353 @default.
• W2989402405 hasConcept C126322002 @default.
• W2989402405 hasConcept C127561419 @default.
• W2989402405 hasConcept C137620995 @default.
• W2989402405 hasConcept C145059251 @default.
• W2989402405 hasConcept C150194340 @default.
• W2989402405 hasConcept C186836561 @default.
• W2989402405 hasConcept C2777387746 @default.
• W2989402405 hasConcept C4692481 @default.
• W2989402405 hasConcept C502942594 @default.
• W2989402405 hasConcept C55493867 @default.
• W2989402405 hasConcept C71924100 @default.
• W2989402405 hasConcept C8415881 @default.
• W2989402405 hasConcept C86803240 @default.
• W2989402405 hasConceptScore W2989402405C104317684 @default.
• W2989402405 hasConceptScore W2989402405C121608353 @default.
• W2989402405 hasConceptScore W2989402405C126322002 @default.
• W2989402405 hasConceptScore W2989402405C127561419 @default.
• W2989402405 hasConceptScore W2989402405C137620995 @default.
• W2989402405 hasConceptScore W2989402405C145059251 @default.
• W2989402405 hasConceptScore W2989402405C150194340 @default.
• W2989402405 hasConceptScore W2989402405C186836561 @default.
• W2989402405 hasConceptScore W2989402405C2777387746 @default.
• W2989402405 hasConceptScore W2989402405C4692481 @default.
• W2989402405 hasConceptScore W2989402405C502942594 @default.
• W2989402405 hasConceptScore W2989402405C55493867 @default.
• W2989402405 hasConceptScore W2989402405C71924100 @default.
• W2989402405 hasConceptScore W2989402405C8415881 @default.
• W2989402405 hasConceptScore W2989402405C86803240 @default.
• W2989402405 hasFunder F4320321549 @default.
• W2989402405 hasFunder F4320322034 @default.
• W2989402405 hasFunder F4320322120 @default.
• W2989402405 hasFunder F4320322349 @default.
• W2989402405 hasIssue "1" @default.

• next